Skip to main content

Table 1 Clinical and pathological characteristics

From: Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node

Clinical and pathological characteristics HLN (N = 17) SLN- (N = 44) SLN+ (N = 14) p-value
Age (mean ± SD) 38.7 ± 11.8 59.1 ± 10.2 52.9 ± 12.9 0.07 A
Primary tumor size (cm)   1.41 ± 0.69 2.67 ± 2.08 0.002 A
T stage     <0.01 B
 T1 (< 2 cm)   38 6
 T2 (≥ 2–5 cm)   6 7
 ≥T3 (> 5 cm)   0 1
Histology     0.72 B
 Ductal   35 12
 Lobular   4 1
 Mixed ductal/lobular   3 0
 Papillary   1 0
 Mucinous   1 1
Differentiation grade     0.35 B
 1   10 3
 2   22 6
 3   12 4
 Unknown   0 1
ER expression     0.39 C
 Yes   39 11
 No   5 3
PR expression     1.00 C
 Yes   35 11
 No   9 3
HER2 amplification     1.00 C
 Yes   8 3
 No   36 11
Breast cancer subtype     0.45 B
 HR positive (ER+ and/or PR+)   39 11
 HER2+   4 1
 TNBC   2 2
  1. Aby two-sided unpaired t-test; B by Pearson chi-square test; C by Fisher’s exact test